These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL. Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289 [Abstract] [Full Text] [Related]
7. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells. Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T. Clin Cancer Res; 2009 Jun 01; 15(11):3725-32. PubMed ID: 19458054 [Abstract] [Full Text] [Related]
9. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Nielsen LL, Dell J, Maxwell E, Armstrong L, Maneval D, Catino JJ. Cancer Gene Ther; 1997 Jun 01; 4(2):129-38. PubMed ID: 9080122 [Abstract] [Full Text] [Related]
13. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer. Oakley R, Phillips E, Hooper R, Wilson D, Partridge M. Clin Cancer Res; 2002 Jun 01; 8(6):1984-94. PubMed ID: 12060644 [Abstract] [Full Text] [Related]
14. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells. Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM. Cancer Gene Ther; 2002 May 01; 9(5):453-63. PubMed ID: 11961668 [Abstract] [Full Text] [Related]
15. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Spitz FR, Nguyen D, Skibber JM, Cusack J, Roth JA, Cristiano RJ. Anticancer Res; 1996 May 01; 16(6B):3415-22. PubMed ID: 9042200 [Abstract] [Full Text] [Related]
16. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells. Kigawa J, Sato S, Shimada M, Kanamori Y, Itamochi H, Terakawa N. Gynecol Oncol; 2002 Feb 01; 84(2):210-5. PubMed ID: 11812076 [Abstract] [Full Text] [Related]
17. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Nishizaki M, Meyn RE, Levy LB, Atkinson EN, White RA, Roth JA, Ji L. Clin Cancer Res; 2001 Sep 01; 7(9):2887-97. PubMed ID: 11555607 [Abstract] [Full Text] [Related]